Loading stock data…
PRVA
$22.65+0.48 (+2.17%)
Market OpenUpdated 3:00 PM EDT
Privia Health Group, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Privia Health Group, Inc. in the Healthcare sector is trading at $22.65. Wall Street consensus targets $31.60 (20 analysts), implying a +39.5% move over the next 12 months. The stock is currently 15% below its 52-week high of $26.51, remaining 2.6% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +39.5% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $603.85M↑ | $541.17M↓ | $580.42M↑ | $521.15M↑ | $480.10M |
| Gross Profit | $60.31M↑ | $49.66M↓ | $63.77M↑ | $50.24M↑ | $45.76M |
| Operating Income | $7.42M↓ | $11.28M↓ | $14.40M↑ | $3.34M↓ | $5.22M |
| Net Income | $3.06M↓ | $9.15M↑ | $6.86M↑ | $2.69M↓ | $4.22M |
Peer Comparison
JNJUNHPFE
Fundamentals
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It also offers technology and population health tools to enhance ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
-
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
2.89%
Volume
Today's trading volume
681,976
Recent News
Privia's CEO Just Sold 121,000 Shares for $2.7 Million
This healthcare technology firm supporting independent physicians reported a notable insider sale.
How The Privia Health Group (PRVA) Narrative Is Shifting With Mixed Targets And New Deals
Privia Health Group’s fair value estimate has been trimmed slightly from US$31.80 to US$31.60, a modest 0.6% reduction in the latest analyst model update. That adjustment lines up with mixed Street commentary, where some firms have lifted targets toward US$35 while others have moved down to around US$24 as they weigh company execution against sector risks. As you read on, you will see how these shifting targets feed into the evolving narrative around Privia Health’s stock. Wall Street's...
Q1 Rundown: Privia Health (NASDAQ:PRVA) Vs Other Healthcare Technology for Providers Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking at healthcare technology for providers stocks, starting with Privia Health (NASDAQ:PRVA).
3 Russell 2000 Stocks with Open Questions
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.
Is Privia Health Stock a Buy After Hedge Fund Rubicon Founders Added Over 175,000 Shares to Its Position?
Privia Health Group delivers technology-driven solutions to optimize physician practices and support value-based care nationwide.